Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Salazar

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Targeted Oncology|November 10, 2009
Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumorsJaume Capdevila, Ramon Salazar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
New approaches but the same flaws in the search for prognostic signaturesRamon Salazar, Josep Tabernero
Nature Reviews. Clinical Oncology|June 15, 2016
Gastrointestinal cancer: Light and shade of intrahepatic arterial radiotherapy in mCRCJosep Tabernero, Ramon Salazar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
Optimizing Anti-EGFR Therapy in Colorectal CancerRamon Salazar, Fortunato Ciardiello
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Multi-target angiokinase inhibitors to fight resistanceOriol Casanovas, Ramon Salazar, Josep Tabernero
Annals of Gastroenterology|April 10, 2014
Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatmentMarc Díez, Alexandre Teulé, Ramon Salazar
Medicina Clinica|August 30, 2006
[Gastrointestinal and pancreatic neuroendocrine tumors]Ramon Salazar, Carlos Villabona, Joan Fabregat
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal CancerRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginningRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Paracrine network: another step in the complexity of resistance to EGFR blockade?Ramon Salazar, Gabriel Capellà, Josep Tabernero
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Targeted Oncology|November 10, 2009
Molecular targeted therapies in the treatment of gastroenteropancreatic neuroendocrine tumorsJaume Capdevila, Ramon Salazar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
New approaches but the same flaws in the search for prognostic signaturesRamon Salazar, Josep Tabernero
Nature Reviews. Clinical Oncology|June 15, 2016
Gastrointestinal cancer: Light and shade of intrahepatic arterial radiotherapy in mCRCJosep Tabernero, Ramon Salazar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
Optimizing Anti-EGFR Therapy in Colorectal CancerRamon Salazar, Fortunato Ciardiello
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Multi-target angiokinase inhibitors to fight resistanceOriol Casanovas, Ramon Salazar, Josep Tabernero
Annals of Gastroenterology|April 10, 2014
Gastroenteropancreatic neuroendocrine tumors: diagnosis and treatmentMarc Díez, Alexandre Teulé, Ramon Salazar
Medicina Clinica|August 30, 2006
[Gastrointestinal and pancreatic neuroendocrine tumors]Ramon Salazar, Carlos Villabona, Joan Fabregat
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal CancerRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginningRodrigo Dienstmann, Ramon Salazar, Josep Tabernero
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2014
Paracrine network: another step in the complexity of resistance to EGFR blockade?Ramon Salazar, Gabriel Capellà, Josep Tabernero
Pageof 14